Abstract
Individuals with lymphedema navigate a particularly complex treatment and self-management regimen, making adherence difficult. It is essential that these individuals conduct lifelong self-care activities to control the progression of swelling, manage lymphedema-associated symptom burden, and minimize long-term negative outcomes (e.g., elephantiasis). Situational, physiological, and psychological factors have the potential to impact adherence to lymphedema management behaviors. It is important for healthcare providers to understand the factors that might influence adherence, as many studies of chronic conditions have shown that adherence improves health-related quality of life. Empirical evidence, however, is lacking for specific behaviors that improve the health-related quality of life of individuals with lymphedema. We postulate that adherence to lymphedema management behaviors decreases symptom burden (i.e., progressive increases in swelling, infection, etc.) and thus facilitates an increase in health-related quality of life. Given the importance of lymphedema self-care, healthcare professionals need to assess and address situational, physiological, and psychological factors that influence adherence.
Highlighted references
Choi E, Nahm FS, Lee PB. Sympathetic block as a new treatment for lymphedema. Pain Physician. 2015;18:365–72.
Coleman MT, Newton KS. Supporting self-management in patients with chronic illness. Am Fam Physician. 2005;72:1503–10.
Lenz ER, Pugh LC, Milligan RA, Gift A, Suppe F. The middle-range theory of unpleasant symptoms: an update. ANS Adv Nurs Sci. 1997;19:14–27.
Ridner SH, Bonner CM, Deng J, Sinclair V. Voices from the shadows: living with lymphedema. Cancer Nurs. 2012;35:E18–26.
Stolldorf DP, Dietrich MS, Ridner SH. A comparison of the quality of life in patients with primary and secondary lower limb lymphedema: a mixed-methods study. West J Nurs Res. 2016;38:1313–34.
World Health Organization (WHO). 2003. Available: http://www.who.int/chp/knowledge/publications/adherence_Section1.pdf. Accessed 15 June 2016.
references
Adler NE, Page AEK. Cancer care for the whole patient: meeting psychosocial health needs. Washington, DC: National Academy Press; 2008.
Akogun OB, Badaki JA. Management of adenolymphangitis and lymphoedema due to lymphatic filariasis in resource-limited North-eastern Nigeria. Acta Trop. 2011;120(Suppl 1):S69–75.
Alcorso J, Sherman KA, Koelmeyer L, Mackie H, Boyages J. Psychosocial factors associated with adherence for self-management behaviors in women with breast cancer-related lymphedema. Support Care Cancer. 2016;24:139–46.
Bani HA, Fasching PA, Lux MM, Rauh C, Willner M, Eder I, Loehberg C, Schrauder M, Beckmann MW, Bani MR. Lymphedema in breast cancer survivors: assessment and information provision in a specialized breast unit. Patient Educ Couns. 2007;66:311–8.
Beaulac SM, Mcnair LA, Scott TE, Lamorte WW, Kavanah MT. Lymphedema and quality of life in survivors of early-stage breast cancer. Arch Surg. 2002;137:1253–7.
Burkhart P, Sabate E. Adherence to long-term therapies: evidence for action. J Nurs Scholarsh. 2003;35:207.
Cormier JN, Askew RL, Mungovan KS, Xing Y, Ross MI, Armer JM. Lymphedema beyond breast cancer. Cancer. 2010;116:5138–49.
Cromwell KD, Chiang YJ, Armer J, Heppner PP, Mungovan K, Ross MI, Gershenwald JE, Lee JE, Royal RE, Lucci A, Cormier JN. Is surviving enough? Coping and impact on activities of daily living among melanoma patients with lymphoedema. Eur J Cancer Care. 2015;24:724–33.
Deng J, Murphy BA, Dietrich MS, Sinard RJ, Mannion K, Ridner SH. Differences of symptoms in head and neck cancer patients with and without lymphedema. Support Care Cancer. 2016;24:1305–16.
Fann JR, Thomas-Rich AM, Katon WJ, Cowley D, Pepping M, Mcgregor BA, Gralow J. Major depression after breast cancer: a review of epidemiology and treatment. Gen Hosp Psychiatry. 2008;30:112–26.
Haas BK. A multidisciplinary concept analysis of quality of life. West J Nurs Res. 1999;21:728–42.
Healthy People 2020. Health-related quality of life & well-being [Online]. Available: https://www.healthypeople.gov/2020/topics-objectives/topic/health-related-quality-of-life-well-being. Accessed June 2016.
Humble CA. Lymphedema: incidence, pathophysiology, management, and nursing care. Oncol Nurs Forum. 1995;22:1503–9; quiz 1510-1.
Jeffs E, Ream E, Shewbridge A, Cowan-Dickie S, Crawshaw D, Huit M, Wiseman T. Exploring patient perception of success and benefit in self-management of breast cancer-related arm lymphoedema. Eur J Oncol Nurs. 2016;20:173–83.
Johnstone P, Hawkins K, Hood S. The role of patient adherence in maintenance of results after lymphedema therapy. J Soc Integr Oncol. 2006;4:125–9.
Kissane D. Beyond the psychotherapy and survival debate: the challenge of social disparity, depression and treatment adherence in psychosocial cancer care. Psycho-Oncology. 2009;18:1–5.
Kusters I, Williams M, Obermair A, Janda M. Women with self-reported lower-limb lymphedema after treatment for gynecological cancers: are they more likely to self-report psychosocial symptoms and less likely to use services? J Commun Support Oncol. 2015;13:55–61.
Lam R, Wallace A, Burbidge B, Franks P, Moffatt C. Experiences of patients with lymphoedema. J Lymphoedema. 2006;1:16–21.
Megari K. Quality of life in chronic disease patients. Health Psychol Res. 2013;1:27.
Megens AM, Harris SR, Kim-Sing C, Mckenzie DC. Measurement of upper extremity volume in women after axillary dissection for breast cancer. Arch Phys Med Rehabil. 2001;82:1639–44.
Narahari SR, Bose KS, Aggithaya MG, Swamy GK, Ryan TJ, Unnikrishnan B, Washington RG, Rao BPS, Rajagopala S, Manjula K, Vandana U, Sreemol TA, Rojith M, Salimani SY, Shefuvan M. Community level morbidity control of lymphoedema using self care and integrative treatment in two lymphatic filariasis endemic districts of South India: a non randomized interventional study. Trans R Soc Trop Med Hyg. 2013;107(9):566–77.
Newman ML, Brennan M, Passik S. Lymphedema complicated by pain and psychological distress: a case with complex treatment needs. J Pain Symptom Manag. 1996;12:376–9.
Norman SA, Localio AR, Potashnik SL, Simoes Torpey HA, Kallan MJ, Weber AL, Miller LT, Demichele A, Solin LJ. Lymphedema in breast cancer survivors: incidence, degree, time course, treatment, and symptoms. J Clin Oncol. 2009;27:390–7.
Ochalek K, Gradalski T, Szygula Z. Five-year assessment of maintenance combined physical therapy in postmastectomy lymphedema. Lymphat Res Biol. 2015;13:54–8.
Okajima S, Hirota A, Kimura E, Inagaki M, Tamai N, Iizaka S, Nakagami G, Mori T, Sugama J, Sanada H. Health-related quality of life and associated factors in patients with primary lymphedema. Jpn J Nurs Sci. 2013;10:202–11.
Ostby PL, Armer JM. Complexities of adherence and post-cancer lymphedema management. J Pers Med. 2015;5:370–88.
Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353:487–97.
Palmer S. Barriers and facilitators to successful lymphedema therapy: the role of adherence. LymphLink. 2006;18.
Paskett ED, Stark N. Lymphedema: knowledge, treatment, and impact among breast cancer survivors. Breast J. 2000;6:373–8.
Passik SD, Mcdonald MV. Psychosocial aspects of upper extremity lymphedema in women treated for breast carcinoma. Cancer. 1998;83:2817–20.
Penha TRL, Botter B, Heuts EM, Voogd AC, Von Meyenfeldt MF, Van der Hulst RR. Quality of life in patients with breast cancer–related lymphedema and reconstructive breast surgery. J Reconstr Microsurg. 2016;32(6):484–90.
Petrek JA, Pressman PI, Smith RA. Lymphedema: current issues in research and management. CA Cancer J Clin. 2000;50:292–307.
Pusic A, Cemal Y, Albornoz C, Klassen A, Cano S, Sulimanoff I, Hernandez M, Massey M, Cordeiro P, Morrow M, Mehrara B. Quality of life among breast cancer patients with lymphedema: a systematic review of patient-reported outcome instruments and outcomes. J Cancer Surviv. 2013;7:83–92.
Radina E, Armer J, Daunt D, Dusold J, Culbertson S. Self-reported management of breast cancer-related lymphoedema. J Lymphoedema. 2007;2:12.
Radina EM, Armer J, Culbertson S, Dusold J. Post-breast cancer lymphedema: understanding women's knowledge of their condition. Oncol Nurs Forum. 2004;31:97–104.
Ridner S, Dietrich M, Kidd N. Breast cancer treatment-related lymphedema self-care: education, practices, symptoms, and quality of life. Support Care Cancer. 2011;19:631–7.
Ridner SH. Quality of life and a symptom cluster associated with breast cancer treatment-related lymphedema. Support Care Cancer. 2005;13:904–11.
Ridner SH, Dietrich MS. Development and validation of the lymphedema symptom and intensity survey-arm. Support Care Cancer. 2015;23:3103–12.
Ridner SH, Rhoten BA, Radina ME, Adair M, Bush-Foster S, Sinclair V. Breast cancer survivors' perspectives of critical lymphedema self-care support needs. Support Care Cancer. 2016;24(6):2743–50.
Sherman KA, Koelmeyer L. Psychosocial predictors of adherence to lymphedema risk minimization guidelines among women with breast cancer. Psycho-Oncology. 2013;22:1120–6.
Smith BG, Hutcheson KA, Little LG, Skoracki RJ, Rosenthal DI, Lai SY, Lewin JS. Lymphedema outcomes in patients with head and neck cancer. Otolaryngol Head Neck Surg. 2014;152(2):284–91.
Towers A, Carnevale FA, Baker ME. The psychosocial effects of cancer-related lymphedema. J Palliat Care. 2008;24:134–43.
Velanovich V, Szymanski W. Quality of life of breast cancer patients with lymphedema. Am J Surg. 1999;177:184–7.
Vignes S, Porcher R, Arrault M, Dupuy A. Long-term management of breast cancer-related lymphedema after intensive decongestive physiotherapy. Breast Cancer Res Treat. 2007;101:285–90.
Vos T, Barber RM, Bell B, Bertozzi-Villa A, Biryukov S, Bolliger I, Charlson F, Davis A, Degenhardt L, Dicker D, Duan L, Erskine H, Feigin VL, Ferrari AJ, Fitzmaurice C, Fleming T, Graetz N, Guinovart C, Haagsma J, Hansen GM, Hanson SW, Heuton KR, Higashi H, Kassebaum N, Kyu H, Laurie E, Liang X, Lofgren K, Lozano R, Macintyre MF, Moradi-Lakeh M, Naghavi M, Nguyen G, Odell S, Ortblad K, Roberts DA, Roth GA, Sandar L, Serina PT, Stanaway JD, Steiner C, Thomas B, Vollset SE, Whiteford H, Wolock TM, Ye P, Zhou M, Ãvila MA, Aasvang GM, Abbafati C, Ozgoren AA, Abd-Allah F, Aziz MIA, Abera SF, Aboyans V, Abraham JP, Abraham B, Abubakar I, Abu-Raddad LJ, Abu-Rmeileh NME, Aburto TC, Achoki T, Ackerman IN, Adelekan A, Ademi Z, Adou AK, Adsuar JC, Arnlov J, Agardh EE, Al Khabouri MJ, Alam SS, Alasfoor D, Albittar MI, Alegretti MA, Aleman AV, Alemu ZA, Alfonso-Cristancho R, Alhabib S, Ali R, Alla F, Allebeck P, Allen PJ, Almazroa MA, Alsharif U, Alvarez E, Alvis-Guzman N, Ameli O, Amini H, Ammar W, Anderson BO, Anderson HR, Antonio CAT, Anwari P, Apfel H, Arsenijevic VSA, Artaman A, Asghar RJ, Assadi R, Atkins LS, Atkinson C, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the global burden of disease study 2013. Lancet. 2015;386:743–800.
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Ridner, S., Deng, J., Rhoten, B.A. (2018). Adherence and Quality of Life. In: Lee, BB., Rockson, S., Bergan, J. (eds) Lymphedema. Springer, Cham. https://doi.org/10.1007/978-3-319-52423-8_39
Download citation
DOI: https://doi.org/10.1007/978-3-319-52423-8_39
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-52421-4
Online ISBN: 978-3-319-52423-8
eBook Packages: MedicineMedicine (R0)